FI874819L - Human rekombinant endotelcell vaextfaktor. - Google Patents

Human rekombinant endotelcell vaextfaktor. Download PDF

Info

Publication number: FI874819L
Authority: FI; Finland
Prior art keywords: vaextfactor; endotelcell; human recombinant; recombinant; human
Prior art date: 1986-03-03

Application number

FI874819A

Other languages

English (en)

Other versions

FI874819A7 (fi

FI874819A0 (fi

Inventor

Michael Jaye

Wilson Burgess

Thomas Maciag

William Drohan

Original Assignee

Rorer Biotechnology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-03

Filing date

1987-03-02

Publication date

1987-11-02

1987-03-02 Application filed by Rorer Biotechnology filed Critical Rorer Biotechnology

1987-11-02 Publication of FI874819A7 publication Critical patent/FI874819A7/fi

1987-11-02 Publication of FI874819L publication Critical patent/FI874819L/fi

1987-11-02 Publication of FI874819A0 publication Critical patent/FI874819A0/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)

FI874819A 1986-03-03 1987-03-02 Human rekombinant endotelcell vaextfaktor. FI874819A0 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/835,594 US4868113A (en)	1986-03-03	1986-03-03	Recombinant DNA vector encoding human endothelial cell growth factor
PCT/US1987/000425 WO1987005332A1 (en)	1986-03-03	1987-03-02	Recombinant human endothelial cell growth factor

Publications (3)

Publication Number	Publication Date
FI874819A7 FI874819A7 (fi)	1987-11-02
FI874819L true FI874819L (fi)	1987-11-02
FI874819A0 FI874819A0 (fi)	1987-11-02

Family

ID=25269917

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI874819A FI874819A0 (fi)	1986-03-03	1987-03-02	Human rekombinant endotelcell vaextfaktor.

Country Status (16)

Country	Link
US (1)	US4868113A (fi)
EP (1)	EP0259475B1 (fi)
JP (4)	JPS63502725A (fi)
KR (1)	KR960002874B1 (fi)
AT (1)	ATE110782T1 (fi)
AU (1)	AU617086B2 (fi)
DE (1)	DE3750451T2 (fi)
DK (1)	DK175807B1 (fi)
FI (1)	FI874819A0 (fi)
HK (1)	HK1002123A1 (fi)
IE (1)	IE66307B1 (fi)
NZ (1)	NZ219485A (fi)
PH (1)	PH24857A (fi)
RU (1)	RU1804480C (fi)
UA (1)	UA13321A (fi)
WO (1)	WO1987005332A1 (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5401832A (en) *	1984-12-24	1995-03-28	Merck & Co., Inc.	Brain derived and recombinant acidic fibroblast growth factor
ATE222602T1 (de) *	1985-09-12	2002-09-15	Scios Inc	Rekombinante fibroblasten-wachstums-faktoren
US5827826A (en)	1986-03-03	1998-10-27	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Compositions of human endothelial cell growth factor
US5552528A (en)	1986-03-03	1996-09-03	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Bovine b-endothelial cell growth factor
NZ220917A (en) *	1986-07-11	1991-05-28	Merck & Co Inc	Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
AU629176B2 (en) *	1987-07-07	1992-10-01	Scios Nova Inc.	Recombinant fibroblast growth factors
US5312911A (en) *	1987-10-22	1994-05-17	Merck & Co., Inc.	Cysteine-modified acidic fibroblast growth factor
NZ226543A (en) *	1987-10-22	1992-02-25	Merck & Co Inc	Recombinant mutant acidic fibroblast growth factor
US5258287A (en) *	1988-03-22	1993-11-02	Genentech, Inc.	DNA encoding and methods of production of insulin-like growth factor binding protein BP53
GB2223496B (en) *	1988-08-08	1992-05-27	British Bio Technology	Synthetic gene encoding mature human acid fibroblast growth factor
GB2223497B (en) *	1988-08-08	1992-04-01	British Bio Technology	Synthetic gene encoding human beta endothelial cell growth factor
ATE141643T1 (de) *	1988-11-04	1996-09-15	Chiron Corp	Expression und prozessierung von acetylierten fgfs in hefen
US5656458A (en) *	1988-11-04	1997-08-12	Chiron Corporation	Expression and processing of amino terminus acetylated FGF's in yeast
US5756686A (en) *	1988-12-20	1998-05-26	Ludwig Institute For Cancer Research	Peptides derived from endothelial cell growth factor
US5227302A (en) *	1988-12-20	1993-07-13	Ludwig Institute For Cancer Research	DNA encoding platelet derived endothelial cell growth factor (PD-ECGF)
US7026291B1 (en)	1989-01-31	2006-04-11	The United States Of America As Represented By The Department Of Health And Human Services	Epithelial cell specific growth factor, keratinocyte growth factor (KGF)
ES2153816T3 (es)	1989-01-31	2001-03-16	Jeffrey S Rubin	Adn que codifica un factor de crecimiento especifico contra celulas epiteliales.
US5595887A (en) *	1990-07-16	1997-01-21	Bionebraska, Inc.	Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
US5244460A (en) *	1991-11-27	1993-09-14	The United States Of America As Represented By The Department Of Health And Human Services	Method to foster myocardial blood vessel growth and improve blood flow to the heart
US5348941A (en) *	1992-04-01	1994-09-20	Merck & Co., Inc.	Stabilizers for fibroblast growth factors
US20050019824A1 (en) *	1994-03-08	2005-01-27	Human Genome Sciences, Inc.	Fibroblast Growth Factor-10
US5656598A (en) *	1994-03-08	1997-08-12	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Use of fibroblast growth factors to stimulate bone growth
US5817485A (en) *	1994-03-08	1998-10-06	Human Genome Sciences, Inc.	Nucleic acids and cells for recombinant production of fibroblast growth factor-10
EP0881908B1 (en) *	1994-03-08	2004-06-16	Osteosa Inc.	Use of fibroblast growth factors to stimulate bone growth
US6551618B2 (en)	1994-03-15	2003-04-22	University Of Birmingham	Compositions and methods for delivery of agents for neuronal regeneration and survival
WO1996039507A1 (en) *	1995-06-05	1996-12-12	Human Genome Sciences, Inc.	Fibroblast growth factor 11
US6110893A (en) *	1995-06-05	2000-08-29	Human Genome Sciences, Inc.	Fibroblast growth factor 11
US6605441B1 (en) *	1995-06-05	2003-08-12	Human Genome Sciences, Inc.	Antibodies against fibroblast growth factor 11
CA2224253A1 (en) *	1995-06-09	1996-12-27	Martin J. Macphee	Chitin hydrogels, methods of their production and use
US5876730A (en) *	1997-08-07	1999-03-02	Childrens Hospital Research Foundation	Heparin-binding growth factor (HBGF) polypeptides
US6645947B1 (en)	1999-05-20	2003-11-11	Chitogenics, Inc.	Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
US6719805B1 (en) *	1999-06-09	2004-04-13	C. R. Bard, Inc.	Devices and methods for treating tissue
WO2002034285A2 (en)	2000-10-20	2002-05-02	Coolidge Thomas R	Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide
US6982170B1 (en)	2001-12-17	2006-01-03	Maine Medical Center Research Institute	Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1
US7265097B2 (en) *	2002-08-20	2007-09-04	Chitogenics, Inc.	Methods of drug delivery using sulphated chitinous polymers
EP1634877B1 (en) *	2004-08-17	2011-06-22	Simpson Biotech Co., Ltd.	Mixture and compounds from mycelia of antrodia camphorata and use thereof
US8357146B2 (en) *	2005-05-18	2013-01-22	Cooltouch Incorporated	Treatment of cellulite and adipose tissue with mid-infrared radiation
US8256429B2 (en) *	2005-05-18	2012-09-04	Cooltouch Incorporated	Treatment of cellulite and adipose tissue with mid-infrared radiation
US8276590B2 (en)	2005-05-18	2012-10-02	Cooltouch Incorporated	Thermally mediated tissue molding
US20070134204A1 (en) *	2005-12-09	2007-06-14	Henrich Cheng	Method for treating nerve injury and vector construct for the same
JP2011121882A (ja) *	2009-12-09	2011-06-23	Eu Sol Biotech Co Ltd	ヒト酸性繊維芽細胞増殖因子の改変ペプチド
KR102736940B1 (ko) *	2021-09-30	2024-12-03	(주)케어젠	항노화 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE222602T1 (de) *	1985-09-12	2002-09-15	Scios Inc	Rekombinante fibroblasten-wachstums-faktoren

1986
- 1986-03-03 US US06/835,594 patent/US4868113A/en not_active Expired - Lifetime
1987
- 1987-03-02 AT AT87902208T patent/ATE110782T1/de not_active IP Right Cessation
- 1987-03-02 WO PCT/US1987/000425 patent/WO1987005332A1/en not_active Ceased
- 1987-03-02 FI FI874819A patent/FI874819A0/fi not_active IP Right Cessation
- 1987-03-02 EP EP87902208A patent/EP0259475B1/en not_active Expired - Lifetime
- 1987-03-02 HK HK98101233A patent/HK1002123A1/en not_active IP Right Cessation
- 1987-03-02 AU AU72012/87A patent/AU617086B2/en not_active Expired
- 1987-03-02 DE DE3750451T patent/DE3750451T2/de not_active Expired - Lifetime
- 1987-03-02 JP JP62502073A patent/JPS63502725A/ja active Pending
- 1987-03-02 UA UA4203874A patent/UA13321A/uk unknown
- 1987-03-02 KR KR1019870701012A patent/KR960002874B1/ko not_active Expired - Lifetime
- 1987-03-03 NZ NZ219485A patent/NZ219485A/xx unknown
- 1987-03-03 PH PH34950A patent/PH24857A/en unknown
- 1987-03-03 IE IE53587A patent/IE66307B1/en not_active IP Right Cessation
- 1987-11-02 RU SU874203874A patent/RU1804480C/ru active
- 1987-11-02 DK DK198705724A patent/DK175807B1/da not_active IP Right Cessation
1995
- 1995-12-12 JP JP34940895A patent/JP3273354B2/ja not_active Expired - Lifetime
1996
- 1996-07-08 JP JP8177653A patent/JPH09294590A/ja active Pending
1997
- 1997-12-03 JP JP33251897A patent/JP3372464B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0259475A1 (en)	1988-03-16
UA13321A (uk)	1997-02-28
NZ219485A (en)	1990-02-26
DK572487A (da)	1987-11-02
DK175807B1 (da)	2005-03-07
PH24857A (en)	1990-12-26
FI874819A7 (fi)	1987-11-02
JPH10175999A (ja)	1998-06-30
JPH09135690A (ja)	1997-05-27
AU7201287A (en)	1987-09-28
AU617086B2 (en)	1991-11-21
RU1804480C (ru)	1993-03-23
WO1987005332A1 (en)	1987-09-11
JP3372464B2 (ja)	2003-02-04
DE3750451D1 (de)	1994-10-06
ATE110782T1 (de)	1994-09-15
FI874819A0 (fi)	1987-11-02
EP0259475B1 (en)	1994-08-31
HK1002123A1 (en)	1998-07-31
US4868113A (en)	1989-09-19
IE870535L (en)	1987-09-03
DK572487D0 (da)	1987-11-02
JPS63502725A (ja)	1988-10-13
EP0259475A4 (en)	1989-10-12
DE3750451T2 (de)	1994-12-22
JP3273354B2 (ja)	2002-04-08
IE66307B1 (en)	1995-12-27
KR880700858A (ko)	1988-04-12
JPH09294590A (ja)	1997-11-18
KR960002874B1 (ko)	1996-02-27

Publication	Publication Date	Title
FI874819L (fi)	1987-11-02	Human rekombinant endotelcell vaextfaktor.
FI872756L (fi)	1987-12-24	Med laserstraolning fungerande terapeutisk anordning.
FI870898A0 (fi)	1987-03-02	Kirurgisk reparationsanordning.
FI873700A0 (fi)	1987-08-26	Kirurgisk protes.
DE3876469D1 (de)	1993-01-21	Hautaequivalent.
FI873185A7 (fi)	1988-01-22	Uusia peptidejä.
DE3784370D1 (de)	1993-04-08	Stulpe.
FI892714A0 (fi)	1989-06-02	Rekombinant-coccidiosisvaccin.
FI875020L (fi)	1988-05-21	Terapeutiska aemnen.
DE3683186D1 (de)	1992-02-13	Rekombinantes humaninterleukin-1.
DE3581730D1 (de)	1991-03-14	Menschlicher tumornekrosisfaktor.
FI853249L (fi)	1985-08-23	Cdna-kloner foer human erytropoietin.
DK551287A (da)	1988-04-24	Polypeptid
FI875456L (fi)	1988-06-14	Manschettkonstruktion.
ATE93321T1 (de)	1993-09-15	Immunotestverfahren.
DE3671886D1 (de)	1990-07-19	Zusammengesetzter koerper.
FI875039L (fi)	1987-11-13	Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
FI883257A7 (fi)	1988-07-07	Uudet peptidit.
FR2597324B1 (fr)	1994-09-16	Laryngoscope.
DK354487A (da)	1988-01-12	Oncogen-relaterede peptider
FI871112L (fi)	1987-09-20	Terapeutiska aemnen.
DE3853743D1 (de)	1995-06-14	Rekombinanter menschlicher ADF.
FI873060A0 (fi)	1987-07-10	Modifierad vaevnads-plasmin-aktivator.
FI864626L (fi)	1987-09-08	Rekombinantricintoxin.
FI861428A7 (fi)	1986-10-04	Rekombinoitu ihmisreniini.

Legal Events

Date	Code	Title	Description
2004-08-31	MM	Patent lapsed	Owner name: RORER BIOTECHNOLOGY INC.